EMBK News and Press, Embark Technology Inc.

NEW YORK, NY / ACCESSWIRE / June 4, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Arlington Asset Investment Corp. (NYSE...

NEW YORK, NY / ACCESSWIRE / May 31, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Radius Global Infrastructure, Inc. (NASDA...

2023-05-26 08:31:34 ET SunCar Technology Group ( SDA ) -27% . Wearable Devices ( WLDS ) -26% . Tilray Brands ( TLRY ) -22% follows $150M convertible note offering . Nano Labs ( NA ) -16% . Beamr Imaging ( BMR ) -15% . HEXO ( ...

2023-05-25 16:39:11 ET Embark Technology ( NASDAQ: EMBK ) said Thursday it will merge with privately held Applied Intuition in an all-cash transaction for $71 million. As per deal terms, Embark shareholders will receive $2.88 per share in cash. For further detail...

Applied Intuition, Inc. to Acquire Embark Technology, Inc. to Enhance Its Products for Autonomous Vehicle Development PR Newswire MOUNTAIN VIEW, Calif. , May 25, 2023 /PRNewswire/ -- Applied Intuition, Inc. , a tooling and software provider for autonomous...

2023-05-24 14:25:34 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable healthcare companies will be added and deleted from Russell microcap index: Notable additio...

2023-05-03 18:44:53 ET Summary Embark is a pre-revenue de-SPAC that has thrown in the towel and is seeking strategic alternatives. Fortunately, its balance sheet holds a substantial cash position. A liquidation, company sale, reverse merger, or CVR could prove to be lucrative ...

2023-03-07 13:30:59 ET Baird stepped to the sidelines on Embark Technology ( NASDAQ: EMBK ) following the company’s decision to lay off hundreds of employees. “We are downgrading to Neutral from Outperform after EMBK recently announced a workforce reduc...

2023-03-06 13:05:55 ET Gainers: Bellerophon ( BLPH ) +86% . Ambrx Biopharma ( AMAM ) +69% . BridgeBio Pharma ( BBIO ) +56% . Avalon GloboCare ( ALBT ) +47% . Azul ( AZUL ) +42% . TCR2 Therapeutics ( TCRR ) +38% . ...

2023-03-06 08:17:23 ET Aclaris Therapeutics ( ACRS ) -38% after preliminary topline data from 12-week Phase 2a study did not meet primary or secondary efficacy endpoints in hidradenitis suppurativa . Esperion Therapeutics ( ESPR ) -27% amid Nexletol data ...